The TGA has rejected safety concerns from dermatologists about rescheduling of topical mometasone and has confirmed it will be made available over the counter in pharmacies from 1 June. In 2019 the Australasian College of Dermatologists strongly opposed an interim decision by the TGA’s Advisory Committee on Medicines Schedule (ACMS) to permit OTC sale of ...
Dermatologist concerns rejected: topical mometasone to be available OTC from June
By Michael Woodhead
18 May 2020